Menu
×
×

Sign Up

Your Profile will be reviewed by Admin
TODAY :
EVENT DATES
Nov 2017
MoTuWeThFrSaSu
  12345
6789101112
13141516171819
20212223242526
27282930   

Venue

Salt Palace Convention Center 100 S. West Temple SMG Admin, 3rd Floor Salt Lake City , Utah 84101
Tel: (385) 468-2222
Website
Google Map

AMP 2017 Annual Meeting - Association for Molecular Pathology

2,000 0

Overview

Event Overview:

The AMP 2017 Annual Meeting will be held November 16-18 at the Calvin L. Rampton Salt Palace Convention Center Salt Lake City, UT.

Corporate Workshop Day will be held on November 15 at the same location. The AMP Annual Meeting is:
The premier educational event for molecular pathology professionals from around the world.
The only educational event developed and presented by internationally renowned molecular diagnostic professionals.
The dedicated forum for first-time presentation of rigorously peer-reviewed abstracts, destined for publication in The Journal of Molecular Diagnostics.
The source for practical applications of clinically proven molecular diagnostics - ultimately improving patient care.

Each year, the AMP Annual Meeting delivers the highest quality content during the three day event. The meeting includes all the essentials such as,
 
      2,000 of your colleagues,
      More than 40 scientific sessions,
      Nearly 100 presentations,
      400+ scientific posters,
      200 exhibiting companies,
      Complimentary meals and coffee breaks,
      A fun-filled social event,
      Countless opportunities to connect with your peers,
      And much more!

The Meeting is preceded on November 15 by the AMP Molecular Pathology Outreach Course (separate registration required) the Science Educator Workshop, and Corporate Workshop Day (free to all - no registration required).

Exhibitor Information:

The AMP Annual Meeting is the only opportunity to connect with nearly 2,000 key decision makers involved in every aspect of molecular diagnostics, including:

Interpretation & Reporting of Molecular Diagnostic Tests

Assay Development, Validation & Performance

Translational Research

Medical Education

Why Exhibit at AMP?

Access to Target Audience
Nearly 2,000 molecular diagnostic professionals gather for the AMP Annual Meeting - the only educational event developed and presented by internationally renowned molecular diagnostic professionals.

Dedicated Exhibit Hours
Meeting attendees are directed to the exhibit hall during coffee breaks and luncheons that are normally held in or adjacent to the hall.  In addition, all poster sessions are held in the exhibit hall.

Exclusive Marketing Opportunities
Only AMP exhibitors may rent the pre-registrant mailing list, host a corporate workshop, earn priority points, and participate in other marketing opportunities designated exclusively for exhibitors.

Product Showcase
The Product Showcase Program is a unique opportunity for exhibiting companies to promote a new product or service in the Exhibit Hall at the AMP Annual Meeting. Product Showcases are open to all Meeting Registrants and seating will be on a first come, first served basis.

About AMP:

The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP's 2,300+ members include individuals from academic and community medical centers, government, and industry; including pathologist and doctoral scientist laboratory directors; basic and translational scientists; technologists; and trainees.

Agenda

Nov 16   

GENERAL INFORMATION

6:30am - 8:00am

Poster Set-Up

6:45am - 5:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

11:30am - 4:30pm

Exhibit Hall Open

5:45pm - 7:00pm

Welcome Reception (In the Exhibit Hall)

(Supported by Roche)

AMP Central Activities (Schedule)

7:00am - 8:00am

Continental Breakfast

SCIENTIFIC INFORMATION

7:00am - 8:00am

EARLY BIRD SESSIONS

Standardization of Projects in Pharmacogenetics

AMP CYP2C19 PGx Variant Standardization Project
Victoria M. Pratt, PhD, Indiana University, Indianapolis, IN, USA

PGx  Standardization Project
Steven A. Schichmann, MD, PhD, John L. McClellan Memorial Veterans Hospital, Little Rock, AR, USA

The Utah Genome Project

Utah Genome Project: Genetic Discovery Powered by Utah's Large Families and Population Database
Deborah Neklason, PhD, University of Utah, Salt Lake City, UT, USA

Molecular Diagnostics for Biomarker-Driven Clinical Trials

The Challenges of Development and Application of the NCI-MATCH NGS Assay

P. Mickey Williams, PhD, Frederick National Labs, Frederick, MD, USA

Pediatric Clinical Trial Networks, Pathologist's Perspective
Marian H. Harris, MD, PhD, Boston Children's Hospital, Boston, MA, USA

Applications of Multiplex Molecular Imaging in Cancer

High Dimensional Imaging of Tumor Immune Infiltrates Using MIBI
Michael Angelo, MD, PhD, Stanford University, Palo Alto, CA, USA

Case Studies in Infectious Diseases and Genetics

Hypertetraploid Partial Molar Pregnancy Identified by Microarray and STR Analysis, with Subsequent Choriocarcinoma Diagnosis
Elizabeth Barrie, PhD, Nationwide Children's Hospital, Columbus, OH, USA

Research Whole Exome Sequencing Identifies a Novel SH2D1A Variant in a 51-Year-Old Patient with CNS Lymphocytic Vasculitis
Patrick Blackburn, PhD, Mayo Clinic, Rochester, MN, USA

Acute Liver Failure Due to Echovirus 9 Associated with Persistent B Cell Depletion from Rituximab
Alex Greninger, MD, PhD, University of Washington, Seattle, WA, USA

Pyrosequencing Solves the Case of the Conflicting Bacterial Isolates
Damon Olson, MD, Baylor College of Medicine, Houston, TX, USA

8:00am - 8:15am

Break

8:15am - 8:30am

Opening Remarks

Daniel E. Sabath MD, PhD
University of Washington, Seattle, WA, USA
2017 Program Chair

8:30am - 9:45am

AMP Award for Excellence in Molecular Diagnostics: Presentation and Lecture

The Epigenetic Basis of Common Human Disease
Andrew P. Feinberg, MD, MPH, Johns Hopkins University School of Medicine, Whiting School of Engineering, and Bloomberg School of Public Health, Baltimore, MD, USA

9:45am -10:15am

Coffee Break

10:15am - 11:45am

ONCOLOGY/CANCER PLENARY SESSION

Molecular Genetics and Biomarkers of B-cell Leukemias and Lymphomas

Precursor B-cell Neoplasms (ALL)
Charles G. Mullighan, MBBS (Hons), MSc, MD, St. Jude Children's Research Hospital, Memphis, TN, USA

Genetic and Epigenetic Drivers of Diffuse Large B Cell Lymphoma
Laura Pasqualucci, MD, Columbia University Medical Center, New York, NY, USA

11:45am - 1:00pm

General Lunch - Visit Exhibit Hall and View Posters

Networking Lunches (Schedule

AMP Central Activities (Schedule)

1:00pm - 2:30pm

CONCURRENT WORKSHOPS

MRD Assessment in Acute Leukemias

A Clinical Trial to Improve Risk Assessment in Acute Myeloid Leukemia that Uses Enhanced Exome Sequencing to Detect Leukemia Clearance Following Therapy
David H. Spencer, MD, PhD, Washington University School of Medicine, St. Louis, MO, USA

Next-generation Sequencing for Detecting MRD in Acute Lymphoblastic Leukemia

David Wu, MD, PhD, University of Washington, Seattle, WA, USA

Discovering the Links: Infectious Agents and Cancer

HPV and Head and Neck Cancer
Joseph A. Califano, MD, University of California, San Diego, CA, USA

Blood-based Assessment of EBV DNA as a Tumor Marker
Jennifer A. Kanakry, MD, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Pharmacogenomics Implementation

Clinical Implementation of Pharmacogenomics: From Reactive Testing to Preemptive Testing
Ann M. Moyer, MD, PhD, Mayo Clinic, Rochester, MN, USA

Implementing and Assessing Outcomes with Genotype-Guided Therapy
Larisa H. Cavallari, PharmD, University of Florida, College of Pharmacy, Gainesville, FL, USA

Bioinformatic Frontiers: Dissecting the Genetics of Cancer

Computational Dissection of Intra-tumor Genetic Heterogeneity and Applications to the Study of Cancer Treatment, Evolution, and Metastasis

Scott L. Carter, PhD, Dana-Farber Cancer Institute, Boston, MA, USA

Strategies and Challenges for Somatic Mutation Detection by Next-gen Sequencing
Daniel C. Koboldt, MSc, Institute for Genomic Medicine at Nationwide Children's Hospital, Columbus, OH, USA

Genetics of Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis: A Timely Review

Perspectives and Diagnostic Considerations in Spinal Muscular Atrophy
Thomas W. Prior, PhD, Ohio State University, Columbus, OH, USA

Genetics of ALS
Vivianna M. Van Deerlin, MD, PhD, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA

 

2:30pm - 4:15pm

Coffee Break - Visit Exhibit Hall, AMP Central (Schedule) and View Posters

4:15pm - 5:45pm

INFECTIOUS DISEASES PLENARY SESSION

The Hunt for Microbes: The Beginning of the End of the Pandemic Era

Microbial Anthropology
Maria G. Dominguez-Bello, PhD, BSc, MSc, New York University School of Medicine, New York, NY, USA

A Collaborative Effort to End the Pandemic Era: The Global Virome Project
Jonna Mazet, DVM, MPVM, PhD, One Health Institute, University of California, Davis, CA, USA

5:45pm - 7:00pm

Welcome Reception (In the Exhibit Hall)

(Supported by Roche)

AMP Central Activities (Schedule)

 

7:00pm - 8:00pm

International Showcase (Separate Registration)

7:00pm - 9:30pm

Canadian Member Dinner

7:00pm - 8:00pm

Trainee Networking Event

7:30pm - 9:00pm

JMD Editorial Board Dinner (Invitation Only)

Nov 17   

GENERAL INFORMATION

6:45am - 5:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

9:00am - 4:00pm

Exhibit Hall Open

7:00am - 8:00am

Continental Breakfast

SCIENTIFIC INFORMATION

7:00am - 8:00am

EARLY BIRD SESSIONS

Novel Technologies: Cool Toys for You Now and in the Future

Gene Expression Profiling During Infection Using Digital Barcoded Probe Technology
Wenjie Xu, PhD, NanoString Technologies, Seattle, WA, USA

Implementation of a Diagnostic Device Syndromic Disease Network 
Lindsay Meyers, BSc, BioFire Diagnostics, LLC, Salt Lake City, UT, USA

Introduction to Smarticles™ Technology: Potential Applications in Antimicrobial Stewardship 
Michael Lewinski, PhD, Roche Molecular Systems, Inc., Pleasanton, CA, USA

Data Visualization

Enabling Scientific Discovery Through Interactive Visual Data Analysis
Alexander Lex, PhD, University of Utah, Salt Lake City, UT, USA

New Tools for Detecting Low Frequency Variants Applications in Hematopoietic Neoplasms

Single Molecule Quantification of Rare DNA and RNA Variants in Heterogeneous Samples
Todd E. Druley, MD, PhD, Washington University School of Medicine, St. Louis, MO, USA

Coding (and Other) Conundrums
(Sponsored by the Economic Affairs Committee)

Panel Discussion
Aaron D. Bossler, MD, PhD, University of Iowa, Iowa City, IA, USA

(EAC Vice-Chair New Codes Subcommittee)

 

Richard D. Press, MD, PhD, Oregon Health & Sciences University, Portland, OR, USA

(EAC Vice-Chair Coverage Subcommittee)

 

Anthony N. Sireci, MD, Columbia University Medical Center, New York, NY, USA  
(EAC Vice-Chair Pricing Subcommittee)

Case Studies in Solid Tumors

A Case of MSI-high Colorectal Cancer Responsive to Checkpoint Blockade Immunotherapy after Progression to Metastatic Disease
Maryam Shirazi, MD, Columbia University Medical Center, New York, NY, USA

RBM10-TFE3: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH Renal Cell Carcinoma
Deepu Alex, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Not So Ancillary: A Case of Correction of Primary Diagnosis with Molecular Studies
Adam Wilberger, MD, University of Colorado Hospital, Aurora, CO, USA

Mutation Signature as a Diagnostic Clue in Lung Carcinoma
Navin Mahadevan, MD, PhD, Brigham and Women's Hospital, Boston, MA, USA

 

8:00am - 9:00am

SPECIAL SESSION: INFECTIOUS DISEASES

Molecular Infectious Disease Testing: Point of Care Challenges

Molecular Point-of-Care Tests for Infectious Diseases: Opportunities and Challenges
Frederick S. Nolte, PhD, Medical University of South Carolina, Charleston, SC, USA

8:00am - 8:15am

Break

8:15am - 9:45am

INFORMATICS PLENARY SESSION

Molecular Informatics at Scale for Genomics-based Personalized Cancer Care

Molecular Pathology Informatics - Toolsets and Infrastructures for Supporting Clinical Trials
Mark Routbort, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Interpreting the Cancer Genome: Identifying Driver Alterations and Therapeutic Options
Nikolaus Schultz, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

9:45am - 10:45am

Coffee Break - Visit Exhibit Hall, AMP Central (Schedule) and View Posters

10:45am - 11:45am

CONCURRENT WORKSHOPS:

Platform Presentations of Selected Abstracts

Abstracts are selected by the Program Committee

Platform Presentations of Selected Genetics Abstracts

G24 - Discovery of Unique Disease- and Gene-specific Peripheral Blood DNA Methylation Signatures Allows Molecular Diagnosis and VUS Classification in Hereditary Genetic Syndromes
Bekim Sadikovic, PhD, London Health Sciences Centre, Western University, Ontario, Canada

G44 - Runs of Homozygosity (ROH) Reveal that Segmental-UPD Occurs as a Result of Recombination Mediated Repair of Genomic Imbalance
Andrea L. Penton, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

G30 - Improved Screening for Cancer Predisposition Mutations in Patients with Advanced Solid Tumors Enabled by Tumor-normal Sequencing
Diana Mandelker, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

G28 - Short Tandem Repeat Analysis Reveals a High Rate of Partial Hydatidiform Moles in Triploid Conceptions Identified by Prenatal Chromosome Microarray
Xuemei Wu, MD, PhD, Oregon Health & Science University, Portland, OR, USA

Platform Presentations of Selected Hematopathology Abstracts

H28 - Haplotype Counting for Sensitive AML Relapse Detection
Marija Debeljak, BSc, Johns Hopkins University, Baltimore, MD, USA

H60 - Comparison of Clinical Digital Karyotyping by Comprehensive Next Generation Sequencing with Standard Cytogenetic Analysis in Pediatric Leukemia
Elizabeth M. Azzato, MD, PhD, St. Jude Children's Research Hospital, Memphis, TN, USA

H68 - Diagnostic Yield of Somatic Mutation Detection in Hematologic Malignancies Does Not Increase with Additional Mutation Analysis, and Supports More Focused Disease-specific Testing Models
Szabolcs Szelinger, PhD, University of California, Los Angeles, CA, USA

H34 - Implementation Considerations: Designing and Medically Vetting a Targeted Gene Panel for Hematologic Malignancies
MIchelle Grant, DO, University of Vermont Medical Center, Burlington, VT, USA

Platform Presentations of Selected Infectious Diseases Abstracts

ID74 - Detection of Resistance-Associated Substitutions in the Hepatitis C Viral Genome using the Sentosa SQ Hepatitis C Virus Genotyping Next-Generation Sequencing Assay
Mihaela Campan, PhD, University of Southern California, Los Angeles, CA, USA

ID02 - Pathogen Detection by Metagenomic Next Generation Sequencing of Purulent Body Fluids
Wei Gu, MD, PhD, University of California, San Francisco, CA, USA

ID34 - Challenges Associated with Developing Rapid Molecular Diagnostics for Detection of Antibiotic Resistance
Megan Stonebraker, Diatherix Laboratories, Huntsville, AL, USA

ID60 - Extreme One-Step RT-PCR: Potential for Point-of-Care Viral Detection
Jessica A. Houskeeper, MRes, University of Utah, Salt Lake City, UT, USA

Platform Presentations of Selected Informatics Abstracts

I06 - A New Allele-centric VCF File for Variants in ClinVar
Melissa J. Landrum, PhD, National Center for Biotechnology, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA

I16 - Homopolymer Compression Improves Reference-Free, Kmer Based Whole Genome Strain Comparison for IonTorrent Data
Keith E. Simmon, PhD, ARUP Laboratories, Salt Lake City, UT, USA

I20 - Redesigning the Molecular Pathology Clinical Report for the Next-generation Genomic Era: The MSKCC Experience with the MSK-IMPACT Assay
Aijazuddin Syed, MSc, Memorial Sloan Kettering Cancer Center, New York, NY, USA

I28 - An Interlaboratory Assessment of Complex Variant Detection Using Multiplexed Positive Controls
Stephen Lincoln, Invitae, San Francisco, CA, USA

Platform Presentations of Selected Solid Tumors Abstracts

ST52 - Clinical Cancer Whole Exome and Transcriptome Sequencing of Pediatric Tumors at Columbia University Medical Center: Laboratory Perspective at Three Years
Susan J. Hsiao, MD, PhD, Columbia University Medical Center, New York City, NY, USA

ST56 - Clinical Utility of Large Scale Genomic Sequencing of Solid Tumors at a Large Academic Medical Center
Noah A. Brown, MD, University of Michigan, Ann Arbor, MI, USA

ST114 - Identification of Germline Variants in Tumor Genomic Sequencing Assays: Usefulness of Variant Allele Fraction and Population Variant Databases
Nathan D. Montgomery, MD, PhD, University of North Carolina, Chapel Hill, NC, USA

ST62 - Integrated Molecular Diagnostic Call Criteria for MET Exon 14 Skipping in Lung Cancer
Ryan J. Schmidt, MD, PhD, Harvard Medical School, Boston, MA, USA

11:45am - 1:00pm

General Lunch - Visit Exhibit Hall and View Posters

Networking Lunches (Schedule

AMP Central Activities (Schedule)

1:00pm - 2:30pm

ONCOLOGY/CANCER PLENARY SESSION

High Impact Molecular Diagnostics for Cancer and Inherited Diseases

Solid Tumor Genotyping: Technical and Clinical Validation with a Focus on Fusions
A. John Iafrate, MD, PhD, Massachusetts General Hospital, Boston, MA, USA

Intersection of Germline and Somatic Cancer Variants and New Areas of Clinical Utility 
Colin C. Pritchard, MD, PhD, University of Washington, Seattle, WA, USA

SPECIAL SESSION: INFECTIOUS DISEASES

Unmet Needs in Infectious Disease Diagnostics

Panel Discussion
Gregory A. Storch, MD, Washington University School of Medicine, St. Louis, MO, USA

Kimberly Hanson, MD, MHS, University of Utah, Salt Lake City, UT, USA

2:30pm - 3:30pm

Coffee Break - Visit Exhibit Hall, AMP Central (Schedule) and View Posters

(Even-numbered posters Attended)

3:30pm - 5:00pm

CONCURRENT SYMPOSIA

Genome Evolution and Therapy Resistance in Lymphoid and Myeloid Neoplasms

Correlation of AML and MDS Mutation Burdens and Response to Decitabine in the Peripheral Blood and Bone Marrow
John S. Welch, MD, PhD, Washington University School of Medicine, St. Louis, MO, USA

Dynamic Monitoring of Lymphoma Genome Evolution
Ash A. Alizadeh, MD, PhD, Stanford University School of Medicine, Stanford, CA, USA

Molecular Testing in the Practice of Cardiology

Phenotype to Genotype: How Traditional Techniques Pave the Way to Targeted Testing and Individualized Medicine
Joseph J. Maleszewski, MD, Mayo Clinic, Rochester, MN, USA

From Genes to Genomes: Evolution of Molecular Testing for Inherited Cardiomyopathies

Birgit Funke, PhD, Veritas Genetics, Danvers, MA, USA
Harvard Medical School, Boston, MA, USA

4:15pm - 5:00pm

SPECIAL SESSION: INFECTIOUS DISEASES

ID Town Hall Meeting

5:00pm - 5:15pm

Break

5:15pm - 6:30pm

Business Meeting and Awards Session

(Open to All Registered Attendees)

7:00pm - 10:30pm

AMP 2017 Social Event

Nov 18   

GENERAL INFORMATION

6:45am - 2:00pm

Attendee, Speaker, and Exhibitor Registration and Check-In

9:00am - 1:30pm

Exhibit Hall Open

12:30pm - 1:30pm

Poster Removal

7:00am - 8:00am

Continental Breakfast

SCIENTIFIC INFORMATION

7:00am - 8:00am

EARLY BIRD SESSIONS

Biorepositories in Precision Medicine

The Role of Biobanks in Precision Medicine Research and Care
Nazneen Aziz, PhD, Kaiser Permanente Research Bank, Oakland, CA, USA

The "All of Us" Research Program- Precision Medicine Initiative: One Million Cohort

Mine S. Cicek, PhD, Mayo Clinic, MN, USA

AMP Bioinformatics Pipeline Validation Working Group
(Sponsored by the Clinical Practice Committee)

AMP Bioinformatics Pipeline Validation Working Group: Development of Guidelines
Somak Roy, MD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

New AMP Guidelines on Validating Next Generation Sequencing Bioinformatics Pipelines
Alexis B. Carter, MD, Children's Healthcare of Atlanta, Atlanta, GA, USA

Molecular Pathology of Pancreatic Neoplasms

Molecular Diagnostic Testing for the Detection of Early Pancreatobiliary Neoplasms
Aatur Singhi, MD, PhD, University of Pittsburgh Medical Center Presbyterian, Pittsburgh, PA, USA

Platform Presentations of Selected Technical Topics Abstracts

TT92 - Successful Extraction of RNA from Archived Bone Marrow Aspirate Smears for Use in Targeted RNA Sequencing
Tamara Restrepo, BSc, Boston Children's Hospital, Boston, MA, USA

TT82 - High Performance Detection of Cancer Mutations from Circulating DNA Using Single Color Digital PCR
Christina Wood-Bouwens, Standford School of Medicine, Department of Oncology, Stanford, CA, USA

TT24 - Screening Circulating Nucleic Acids of Pancreatic Ductal Adenocarcinoma Using a Plasmonic Nanosensor
Amogha Tadimety, Dartmouth College, Hanover, NH, USA

TT76 - Engineering of Isogenic Cell Lines Using the CRISPR/Cas9 Technology and Precise Characterization of Low Allelic Frequency FFPE Cell Line Blocks for Use as Molecular Reference Standards
Andrew Hilmer, PhD, Applied Stem Cell, Milpitas, CA, USA

Case Studies in Hemepath and Informatics

Inv(16) Incidentally Detected by Leukemia Translocation Panel Screen in a Patient with Therapy-related Acute Myeloid Leukemia
Andres E. Quesada, MD, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

A Confounding Case of Polycythemia Vera
Aaron Atkinson, PhD, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA

Identifying Patients at Risk for Myelodysplastic Syndrome through Next Generation Sequencing of Cytopenias with Equivocal or Absent Morphologic Dysplasia
Patrick Mann, MD, Washington University, St. Louis, MO, USA

Detection of the Controversial ASXL1 c.1934dupG (p.G646Wfs*12) Insertion Variant From Targeted Next-generation Sequencing (NGS) Data
Michael Alberti, MD, PhD, Washington University, St. Louis, MO, USA

 

 

8:00am - 9:00am

SPECIAL SESSION: INFECTIOUS DISEASES

Technologist Round Table: Troubleshooting in Molecular ID Lab

Passing the Baton: Keys to Successful Implementation of Laboratory Developed Tests (LDTs) and FDA-cleared Tests
Melissa R. Johnson, BSc, ARUP Laboratories, Salt Lake City, UT, USA

Jeff Stevenson, PhD, ARUP Laboratories, Salt Lake City, UT, USA

Jeffrey Chumley, BSc, ARUP Laboratories, Salt Lake City, UT, USA

8:00am - 8:15am

Break

8:15am - 9:45am

INHERITED CONDITIONS PLENARY SESSION

Mitochondrial Disease: Diagnosis, Treatment and Prevention

Overview of Mitochondrial Disease and Nuclear Genetic Causes
Marni J. Falk, MD, Children's Hospital of Philadelphia, Philadelphia, PA
University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

Mitochondrial DNA Disease: Etiology, Diagnosis, and Prevention
Sir Doug Turnbull, MBBS, MD, PhD, Newcastle University, Newcastle, UK

9:45am - 10:45am

Coffee Break - Visit Exhibit Hall, AMP Central (Schedule) and View Posters

(Odd-numbered posters Attended)

10:45am - 12:15pm

CONCURRENT WORKSHOPS

Whole Exome Sequencing in Clinical Practice

Development and Validation of a Whole-exome Sequencing Test for Simultaneous Detection of Point Mutations, Indels and Copy-number Alterations for Precision Cancer Care
Oliver Elemento, PhD, Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA

 

Integrated Genomic Profile Using Clinical Whole Genome and Transcriptome Sequencing to Enable Precision Oncology 
Vaidehi Jobanputra, PhD, New York Genome Center, New York, NY, USA

Crowd-sourcing the Expert Curation of Germline and Somatic Variants: CIViC, ClinGen and Clinvar

ClinGen and ClinVar: Building Resources to Support Gene and Variant Interpretation

Heidi L. Rehm, PhD, Harvard Medical School, Boston, MA, USA

CIViC: A Curation Portal and Knowledgebase for Cancer Variant Interpretation

Obi L. Griffith, PhD, Washington University School of Medicine, St. Louis, MO, USA

Molecular Detection of Resistance: Ready for Prime Time?

Bacterial Resistance:  Detection with Molecular Methods
Robert A. Bonomo, MD, Louis Stokes VA Medical Center, Cleveland, OH, USA

 

Deep Sequencing for HIV-1 Clinical Management 
Maria Casadellà, PhD, IrsiCaixa AIDS Research Institute, Barcelona, Spain

Review and Implementation of New AMP Guidelines on NGS Somatic Variant Test Validation, Interpretation, and Reporting
(Sponsored by the Clinical Practice Committee)

 

AMP/CAP Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels

Lawrence J. Jennings, MD, PhD, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA

 

AMP/ASCO/CAP Standards and Guidelines of Somatic Variant Interpretation and Reporting
Marilyn M. Li, MD, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA

 

Implementation of NGS Somatic Variant Guidelines into Clinical Practice
Marina N. Nikiforova, MD, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

What is the Legal Risk for Interpreting and Classifying Sequencing Variants in the Laboratory
(Sponsored by the Professional Relations Committee)

Panel Discussion

John D. Pfeifer, MD, PhD, Washington University School of Medicine, St. Louis, MO, USA

 

Robert Cook-Deegan, Arizona State University, Washington, DC, USA

 

Wayne W. Grody, MD, PhD, UCLA School of Medicince, Los Angeles, CA, USA

 

Jamie McDonald, MSc, University of Utah, Salt Lake City, UT, USA

 

Elaine Lyon, PhD, ARUP Laboratories, Salt Lake City, UT, USA and Past AMP President

 

12:15pm - 1:30pm

General Lunch - Visit Exhibit Hall, and View Posters

Networking Lunches (Schedule

AMP Central Activities (Schedule)

1:30pm - 3:00pm

CONCURRENT SYMPOSIA

C. difficile Testing: Pros and Cons of Testing Algorithms

Diagnosis of Clostridium difficile Infections: The Benefits of Molecular Testing
Ferric C. Fang, MD, University of Washington, School of Medicine, Seattle, WA, USA

Diagnosis of Clostridium difficile Infections: Why Toxin Tests Still Matter
Christopher R. Polage, MD, MAS, University of California, Davis School of Medicine, Sacramento, CA, USA

Emerging Technology for Structural Variant Detection

Mate-Pair Sequencing in Cytogenetics
Nicole L. Hoppman, PhD, Mayo Clinic, Rochester, MN, USA

Digital Karyotyping and Complex Rearrangement Analysis with Sequencing at Single Molecule Resolution
Hanlee P. Ji, MD, Stanford University School of Medicine, Stanford, CA, USA

3:00pm - 3:15pm

Break

3:15pm - 4:45pm

GENERAL MOLECULAR TECHNOLOGIES PLENARY SESSION

Role of Genome Editing in Research and Therapy

Genome Editing with CRISPR-Cas Nucleases
J. Keith Joung, MD, PhD, Massachusetts General Hospital, Charlestown, MA, USA

Accelerating Prediction of Tumor Vulnerabilities Using Next-generation Cancer Models
Jesse S. Boehm, PhD, Broad Institute, Cambridge, MA, USA

4:45pm - 5:00pm

Closing Remarks

Daniel E. Sabath MD, PhD
Director, Red Cell Disorders, Molecular Diagnosis and General Laboratories, University of Washington
2017 Program Chair

Photos +

Videos +

RELATED EVENTS +

MORE events +

Display Makers +